Life Sciences and Biotechnology

We’ve Spoken To Your Customers

Understanding the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever before. Customer experience offers an opportunity for suppliers to differentiate themselves from other suppliers in a crowded life science marketplace on something more than product performance and price. An excellent…

For most manufacturing facilities in the food industry, laboratories must first test the raw materials that are purchased from an external supplier or farm. This must occur before they are allowed to be processed by the manufacturer. As the raw materials are processed, they are usually tested or monitored in some way. Samples tested during…

Environmental testing is a key area of the global analytical instrumentation market that looks at qualitatively and/or quantitatively analyzing contaminants in the environment. These contaminants can take many forms, from toxic chemicals in drinking water as the result of industrial processes to small particulate matter in the air we breathe. In order to protect from…

The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.

Updated June 2020 to reflect the COVID-19 and related lab closure situation.

This report provides detailed data on every major life science and analytical instrument technology…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. Unlike small molecule drugs, these biomolecule-based therapeutics, or biologics, are produced using living cells in two distinct phases, called upstream and downstream, which necessitates unique manufacturing processes collectively…

Contract research organizations (CROs) are essential partners in the drug development field. As companies in the pharmaceutical and biotechnology industries shift their development pipelines towards more targeted therapies, the cost of development has significantly increased while the patient pool for each drug is smaller. This has resulted in leaner R&D infrastructures and increasing reliance on…

What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

The pharma/bio sector is one of the highest growing markets in the world, driven by innovations that aim to provide better medication and healthcare for mankind. The development and production of these therapeutics is a costly and lengthy process which is highly regulated at all steps. With significant investments required for R&D, manufacturing, and quality…

First published by BioInformatics in 2003, Advertising to Life Scientists is the indispensable guide to reaching your scientific audience. Improve the effectiveness of your advertising by understanding the messages and media that scientists consider most useful and appropriate.

This report explores the preferences, opinions, and impact of print and digital advertising on life scientists. This report provides…

Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including…